Figure 1.
Study design for ublituximab. CLL, chronic lymphocytic leukaemia; NHL, aggressive non‐Hodgkin lymphoma; PD, progressive disease; SLL, small lymphocytic lymphoma.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.